{"gene":"ELOVL4","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":2001,"finding":"ELOVL4 encodes a retinal photoreceptor-specific protein with homology to yeast proteins involved in biosynthesis of very long chain fatty acids; a 5-bp deletion in exon 6 causes protein truncation and is associated with autosomal dominant Stargardt-like macular dystrophy (STGD3).","method":"Recombination breakpoint mapping, direct sequencing, bioinformatic homology analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic mapping plus sequencing, replicated across multiple families and independently confirmed by multiple subsequent studies","pmids":["11138005"],"is_preprint":false},{"year":2004,"finding":"Wild-type ELOVL4 localizes predominantly to the endoplasmic reticulum (ER) in COS-7 and CHO cells, dependent on a C-terminal dilysine (KXKXX) ER retention/retrieval motif; disease-associated truncation mutants lose ER localization and are redirected to the Golgi compartment.","method":"Immunofluorescence with organelle-specific markers, immunoelectron microscopy in human photoreceptors, transfection of COS-7 and CHO cells","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal localization methods, validated in human photoreceptors, replicated across multiple independent studies","pmids":["15028284"],"is_preprint":false},{"year":2004,"finding":"Wild-type ELOVL4 localizes to the ER and not to mitochondria, peroxisomes, or Golgi; mutant ELOVL4 (lacking ER retention signal) mislocalizes to cytoplasmic aggregates and induces apoptotic cell death in transfected cells.","method":"Confocal microscopy with organelle-specific markers (ER, mitochondria, peroxisomes, Golgi), TUNEL staining, Western blot in NIH-3T3 and HEK293 cells","journal":"Molecular vision","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple organelle markers used, functional apoptosis readout, single lab","pmids":["15073583"],"is_preprint":false},{"year":2004,"finding":"A novel Y270X truncation mutation in ELOVL4 causes mislocalization of the mutant protein away from the ER in NIH-3T3 and HEK293 cells, consistent with loss of the ER retention signal.","method":"Transfection with EGFP fusion proteins, confocal microscopy with ER marker (pDsRed2-ER), Western blot","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, fluorescence localization, consistent with other reports","pmids":["15557430"],"is_preprint":false},{"year":2005,"finding":"Disease-associated C-terminal truncation mutants of ELOVL4 accumulate in aggresome-like juxtanuclear inclusions; wild-type ELOVL4 co-immunoprecipitates with mutant ELOVL4 and is recruited into these aggresomes, establishing a dominant negative mechanism that alters wild-type protein subcellular localization.","method":"Immunofluorescence, co-immunoprecipitation, immunoaffinity chromatography in COS-7 and HEK293T cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP plus immunofluorescence colocalization, replicated by multiple independent groups","pmids":["16036915"],"is_preprint":false},{"year":2005,"finding":"ELOVL4 5-bp deletion mutant interacts with wild-type ELOVL4 and recruits it into perinuclear aggresome-like inclusions; interaction demonstrated by 2D gel electrophoresis and FRET analysis in COS-7 cells.","method":"Immunocytochemistry, 2D gel electrophoresis, FRET analysis, Western blot in COS-7 cells","journal":"Molecular vision","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRET directly demonstrates protein-protein interaction, two orthogonal methods, single lab","pmids":["16163264"],"is_preprint":false},{"year":2005,"finding":"ELOVL4 truncation mutants cause loss of ER retention and sequestration of wild-type ELOVL4 into non-ER aggregates; mutant expression induces the unfolded protein response (UPR) as evidenced by upregulation of BiP and CHOP.","method":"Fluorescence microscopy, co-immunoprecipitation, sucrose gradient centrifugation with immunodetection, Western blot for BiP and CHOP in HEK293 and COS cells","journal":"Molecular vision","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods, UPR markers measured, single lab","pmids":["16145543"],"is_preprint":false},{"year":2007,"finding":"ELOVL4 is required for synthesis of very long chain fatty acids (≥C28) in skin; homozygous loss-of-function (knock-in 5-bp deletion) in mice depletes C28+ ceramides and free fatty acids, eliminates epidermal omega-O-acylceramides essential for stratum corneum lamellar membranes, and causes lethal epidermal permeability barrier failure.","method":"Knock-in mouse model, lipid analysis of epidermis, electron microscopy of lamellar bodies, histopathology, transepidermal water loss measurements","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic loss-of-function with defined biochemical (lipid depletion) and structural phenotype, independently replicated by multiple groups","pmids":["17208947"],"is_preprint":false},{"year":2007,"finding":"Homozygous knockout of Elovl4 in mice depletes epidermal ceramides containing omega-hydroxy VLC-FAs (≥C28) and causes accumulation of C26-ceramides, implicating C26 fatty acids as substrates for ELOVL4; skin water permeability barrier failure leads to neonatal death.","method":"Elovl4 knockout mice, lipidomic analysis of ceramide fractions, histology of skin, transepidermal water loss","journal":"International journal of biological sciences","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic KO with biochemical substrate identification, replicated independently","pmids":["17311087"],"is_preprint":false},{"year":2007,"finding":"Elovl4 knockout mice lacking functional ELOVL4 show a significant reduction in free fatty acids longer than C26 in skin, establishing that ELOVL4 elongates C26 and longer fatty acids in vivo.","method":"Elovl4 Y270X mutant and knockout mice, biochemical fatty acid analysis of skin","journal":"International journal of biological sciences","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic loss-of-function with biochemical product identification, replicated across multiple labs","pmids":["17304340"],"is_preprint":false},{"year":2007,"finding":"Heterozygous knock-in of the 5-bp deletion in Elovl4 does not cause retinal degeneration, establishing that haploinsufficiency is not the disease mechanism in STGD3; instead, dominant negative effects of mutant protein are required.","method":"Heterozygous Elovl4 knockout mice, electroretinography, retinal morphology, Western blot, fatty acid profiling","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via KO vs. knock-in comparison, replicated across multiple groups","pmids":["16877435","17254625"],"is_preprint":false},{"year":2007,"finding":"In Stgd3 knock-in mouse retinas, selective deficiency of C32-C36 acyl phosphatidylcholines (but no detectable cellular stress response) was found, indicating that loss of these specific lipid products rather than mutant protein toxicity underlies retinal pathology.","method":"Lipid mass spectrometry of knock-in mouse retinas, analysis of cellular stress markers","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mass spectrometry-based lipidomics in disease model, single lab","pmids":["17983602"],"is_preprint":false},{"year":2008,"finding":"ELOVL4 directly catalyzes the elongation of C24:0 to C28:0 and C30:0 saturated fatty acids, and elongates C20:5n3 and C22:5n3 to a series of C28-C38 VLC-PUFAs; this was the first direct experimental evidence for ELOVL4 elongase activity.","method":"Gain-of-function adenoviral expression of mouse Elovl4 in rat neonatal cardiomyocytes and ARPE-19 cells, supplementation with labeled FA precursors, fatty acid profiling","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical gain-of-function assay with substrate identification, highly cited and foundational","pmids":["18728184"],"is_preprint":false},{"year":2010,"finding":"ELOVL4 protein does not participate in the biosynthesis of docosahexaenoic acid (DHA, 22:6n3) from shorter-chain precursors (18:3n3 and 22:5n3); siRNA-mediated silencing of ELOVL4 in 661W cone cells did not reduce DHA synthesis.","method":"siRNA knockdown of ELOVL4 in 661W cells, fatty acid analysis","journal":"Advances in experimental medicine and biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, direct KD experiment with negative result, but negative finding is mechanistically informative","pmids":["20238022"],"is_preprint":false},{"year":2011,"finding":"Photoreceptor-specific conditional knockout of Elovl4 in mice causes significant decrease in retinal glycerophospholipids containing VLC-PUFAs (specifically in the sn-1 position of phosphatidylcholine), abnormal lipid droplet and lipofuscin accumulation, and photoreceptor-specific defects in visual response.","method":"Photoreceptor-specific conditional Elovl4 knockout mice, HPLC-MS lipid analysis, immunofluorescence, histology, electroretinography","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — conditional KO with precise lipidomic and functional characterization, multiple orthogonal methods","pmids":["22199362"],"is_preprint":false},{"year":2011,"finding":"ELOVL4 protein preferentially elongates 20:5n3 (EPA) over 20:4n6 and 22:6n3 (DHA) to produce C28-C38 VLC-PUFAs; only ELOVL4-expressing cells synthesize these VLC-PUFAs from C20-C22 PUFA precursors.","method":"Expression of ELOVL4 in pheochromocytoma cells, supplementation with individual FA substrates and combinations, GC-MS fatty acid profiling","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct enzymatic assay in cell culture, single lab but multiple substrate conditions","pmids":["22158834"],"is_preprint":false},{"year":2013,"finding":"The STGD3-associated truncated ELOVL4 mutant lacks intrinsic condensation (elongase) activity in cell-based and cell-free microsome assays; co-expression of mutant with wild-type ELOVL4 shows a large dominant negative effect, reducing ELOVL4 localization to ER and enzymatic activity, resulting in reduced VLC-PUFA synthesis.","method":"Cell-based and cell-free microsome elongase assays, co-expression studies, VLC-PUFA quantification","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct enzymatic assay with cell-free reconstitution, dominant negative mechanism mechanistically established","pmids":["23509295"],"is_preprint":false},{"year":2013,"finding":"Photoreceptor-specific ablation of Elovl4 in rods (conditional KO) depletes retinal VLC-PUFAs by up to 98% but causes no electrophysiological or behavioral deficits, whereas transgenic expression of mutant ELOVL4 (STGD3 allele) causes rod-cone dystrophy despite similar VLC-PUFA depletion; this suggests the mutant protein itself (not simply VLC-PUFA depletion) drives STGD3 pathology.","method":"Rod- and cone-specific conditional KO mice vs. STGD3 transgenic mice, GC-MS for VLC-PUFA, electroretinography, optomotor tracking, electron microscopy","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct genetic epistasis comparing conditional KO and transgenic models with multiple orthogonal phenotypic readouts","pmids":["23479632"],"is_preprint":false},{"year":2014,"finding":"ELOVL4 enzymatic activity requires specific conserved histidine residues in its active site (active site histidine mutants lack condensation activity) and requires ER localization (displacing ELOVL4 from ER abolishes activity); N-glycosylation is not required for enzyme function.","method":"Active-site histidine mutagenesis, ER-retention mutants, N-glycosylation-deficient mutants expressed in cell culture, fatty acid elongation assays","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 / Strong — active-site mutagenesis directly establishing catalytic mechanism, multiple mutant variants tested","pmids":["24569140"],"is_preprint":false},{"year":2014,"finding":"In Xenopus laevis transgenic rods, wild-type ELOVL4 localizes to inner segments, while the STGD3 dilysine-deficient mutant is mislocalized to post-Golgi compartments and outer segment disks; co-expression of mutant and wild-type ELOVL4 in rods did NOT result in mislocalization of wild-type protein to outer segments or aggregate formation in vivo.","method":"Transgenic Xenopus laevis expressing HA-tagged ELOVL4 variants in rods, immunofluorescence microscopy","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo localization in photoreceptors, contrasts with cell culture studies, single lab","pmids":["24833735"],"is_preprint":false},{"year":2014,"finding":"ELOVL4 is expressed in meibomian glands and sebaceous glands; Stgd3 mutant mice show meibomian gland abnormalities and increased blink rates resembling evaporative dry eye, establishing a role for ELOVL4-dependent VLC-FAs in meibomian gland function.","method":"Immunohistochemistry, hematoxylin-eosin staining, clinical ocular phenotyping of Stgd3 mice","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — loss-of-function mouse model with tissue-specific localization and anatomical phenotype, single lab","pmids":["24677106"],"is_preprint":false},{"year":2010,"finding":"The STGD3 truncated ELOVL4 mutant (ELOVL4ΔC) forms homo-oligomers more strongly than wild-type ELOVL4, and also forms hetero-oligomers with other elongases (ELOVL1-7) more strongly than wild-type; ELOVL4ΔC can form elongase complexes with other components of the VLCFA elongation machinery.","method":"Co-immunoprecipitation in HEK293T cells, elongase activity assays for multiple acyl-CoA substrates","journal":"Molecular vision","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — reciprocal co-IP with multiple binding partners, enzymatic activity assays, single lab","pmids":["21139992"],"is_preprint":false},{"year":2011,"finding":"Transgenic expression of ELOVL4 driven by an epidermal-specific involucrin promoter in homozygous Stgd3 mice restores synthesis of epidermal C28-C36 acylceramides and (O-linoleoyl)-omega-hydroxy C28-C36 fatty acids, rescues skin barrier function, and prevents neonatal lethality; establishes that ELOVL4 is the sole enzyme synthesizing these lipids in skin.","method":"Skin-specific transgenic rescue of Elovl4 expression in homozygous Stgd3 mice, lipidomic analysis, transepidermal water loss, survival assessment","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic rescue experiment directly linking ELOVL4 enzymatic products to barrier function and survival","pmids":["21429867"],"is_preprint":false},{"year":2017,"finding":"Double transgenic mice with homozygous STGD3 Elovl4 mutation (skin-rescued) develop seizures and die by P21; cultured hippocampal neurons from these mice show accelerated synaptic vesicle release kinetics (FM1-43 dye assay), which is rescued by supplementation with VLC-SFAs; establishing that ELOVL4-derived VLC-SFAs regulate presynaptic neurotransmitter release kinetics and epileptogenesis.","method":"Skin-specific rescue transgenic + homozygous knock-in mice, hippocampal slice electrophysiology, FM1-43 synaptic vesicle release assay, VLC-SFA supplementation rescue","journal":"Molecular neurobiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic model with direct rescue by VLC-SFA supplementation, electrophysiology, multiple orthogonal methods","pmids":["29168048"],"is_preprint":false},{"year":2018,"finding":"ELOVL4-derived very long chain ceramides (VLC-ceramides, ≥C26) colocalize with tight junction complexes in retinal endothelial cells; ELOVL4 overexpression stabilizes tight junctions and prevents VEGF- and IL-1β-induced permeability; intravitreal AAV2-hELOVL4 delivery reduces diabetes-induced retinal vascular permeability.","method":"ELOVL4 overexpression and AAV delivery in cell culture and mouse model, permeability assays, ultrastructural and lipidomic analysis, Western blot for TJ proteins","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function in vitro and in vivo with mechanistic TJ protein readouts and lipidomic colocalization, multiple orthogonal methods","pmids":["29362226"],"is_preprint":false},{"year":2021,"finding":"VLC-PUFA-containing lipids are enriched in photoreceptor outer segment disks; in neurons, VLC-SFAs are enriched in synaptic vesicles where they regulate the kinetics of presynaptic neurotransmitter release essential for normal neuronal function.","method":"Lipid fractionation, mass spectrometry in retina and brain, synaptic vesicle preparations, electrophysiology in VLC-SFA-deficient mice","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — review synthesizing multiple prior experimental findings from same group, original data cited in incorporated studies","pmids":["33556440"],"is_preprint":false},{"year":2020,"finding":"The W246G ELOVL4 knock-in rat (SCA34 model) shows that the W246G mutation selectively impairs VLC-SFA synthesis but not VLC-PUFA synthesis in retina and skin; homozygous rats show reduced ERG a- and b-wave amplitudes (retinal dysfunction) without photoreceptor degeneration, revealing a role for VLC-SFAs in regulating retinal function independent of neurodegeneration.","method":"Knock-in rat model, GC-MS lipid analysis, electroretinography, optical coherence tomography, histology, immunolabeling","journal":"Molecular neurobiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — knock-in rat model with precise lipid biochemistry separating VLC-SFA vs VLC-PUFA contributions, multiple orthogonal phenotypic measures","pmids":["32780351"],"is_preprint":false},{"year":2021,"finding":"W246G mutant ELOVL4 rats (SCA34 model) show impaired long-term potentiation at parallel fiber-Purkinje cell synapses and impaired long-term depression at climbing fiber-Purkinje cell synapses, with early motor deficits but no cerebellar neurodegeneration at 6 months; establishing that ELOVL4 VLC-SFAs are required for cerebellar synaptic plasticity.","method":"Knock-in rat, cerebellar slice electrophysiology (LTP/LTD recordings), rotarod motor testing, neuroanatomical analysis","journal":"Molecular neurobiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — electrophysiology with defined synaptic plasticity readouts in genetic model, multiple orthogonal methods","pmids":["34227061"],"is_preprint":false},{"year":2022,"finding":"SCA34-causing ELOVL4 mutations L168F and W246G are deficient in VLC-SFA biosynthesis (especially W246G, which shows negligible VLC-SFA synthesis) but retain VLC-PUFA biosynthetic capability; L168F shows a gain-of-function producing 38:5n3 not made by WT; this differential loss of VLC-SFA vs. VLC-PUFA production may explain tissue-specific pathology (brain/skin but not retina) in SCA34.","method":"Expression of WT and mutant ELOVL4 in cell culture, supplementation with VLC-PUFA and VLC-SFA precursors, GC-MS quantification of FA methyl esters","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct enzymatic assay comparing multiple disease-causing variants, two substrate classes tested, clear mechanistic differentiation","pmids":["36464075"],"is_preprint":false},{"year":2023,"finding":"Five SCA34-causing ELOVL4 mutants produce shorter ultra-long-chain (ULC) polyunsaturated FA-containing phosphatidylcholines than wild-type; structural modeling places substituted residues in transmembrane helices interacting with the ω-end region of the substrate acyl-CoA, explaining incomplete elongation; heterozygous Q180P and homozygous W246G mouse embryonic stem cells show neuronal differentiation-dependent reduction of ULC-PCs.","method":"Cell-based phosphatidylcholine elongation assay for 5 SCA34 mutants, knock-in mouse embryonic stem cells, neuronal differentiation, lipidomics, structural modeling","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct enzymatic assay for multiple mutants plus knock-in stem cell model with neuronal differentiation, structural model for mechanism","pmids":["36748939"],"is_preprint":false},{"year":2023,"finding":"In W246G ELOVL4 mutant rat cerebellum, miniature EPSC frequency (but not amplitude) is reduced at Purkinje cell synapses, indicating a presynaptic defect in excitatory transmission; miniature IPSC frequency and amplitude are increased; paired-pulse ratio changes suggest opposite effects on release probability at parallel fiber vs. climbing fiber synapses; dendritic spine density is reduced in Purkinje cells.","method":"Patch-clamp electrophysiology (mEPSC, mIPSC recordings), paired-pulse ratio, high-frequency stimulation, dendritic spine morphometry in SCA34 knock-in rats","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — detailed patch-clamp recordings identifying specific presynaptic and postsynaptic mechanisms, multiple synaptic parameters measured","pmids":["37491316"],"is_preprint":false},{"year":2023,"finding":"Elovl4 is a downstream target of the NOTCH-RIPK4-IRF6 tumor suppressor axis in epidermis; loss of Elovl4 in skin triggers squamous cell carcinoma development, and overexpression of Elovl4 suppresses tumor growth in Ripk4-deficient keratinocytes.","method":"Autochthonous mouse tumor models (Pik3caH1047R oncogene), in vivo CRISPR screening, Elovl4 loss-of-function and overexpression rescue experiments in keratinocytes","journal":"Cancers","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo CRISPR screen combined with rescue overexpression and multiple genetic models establishes pathway position","pmids":["36765696"],"is_preprint":false},{"year":2018,"finding":"In rat spermatocytes, ELOVL4 protein is a germ cell-specific product (absent from Sertoli cells), displays the highest protein levels and elongase activity in spermatocytes, and is responsible for elongation of arachidonate to C26-C32 polyunsaturated FAs present in germ cell sphingolipids.","method":"Immunohistochemistry, Western blot, [3H]arachidonate radiolabeled elongation assay in isolated germ cell populations and Sertoli cells","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct radiolabeled substrate assay in primary cell populations, cell-type-specific protein expression confirmed, single lab","pmids":["29724783"],"is_preprint":false},{"year":2023,"finding":"A novel L168S ELOVL4 variant is deficient in both VLC-SFA and VLC-PUFA biosynthesis in cell culture, differentiating it from L168F (which retains VLC-PUFA synthesis) and suggesting combined VLC-SFA and VLC-PUFA deficiency underlies early-childhood SCA34 with retinal dysfunction.","method":"Expression of L168S ELOVL4 variant in cell culture, supplementation with VLC-PUFA and VLC-SFA precursors, GC-MS fatty acid profiling","journal":"Acta neuropathologica communications","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct enzymatic assay, single lab, single variant studied","pmids":["37568198"],"is_preprint":false},{"year":2020,"finding":"SCA34 patient-derived fibroblasts show mislocalization of ELOVL4 protein appearing punctate and aggregated (not in normal ER distribution), supporting dominant negative effect of the L168F mutation on protein localization in human cells.","method":"Immunohistochemistry of patient-derived dermal fibroblasts","journal":"Neurology. Genetics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single localization method in patient cells, no functional readout, single lab","pmids":["32211516"],"is_preprint":false},{"year":2021,"finding":"MYCN binds to the ELOVL4 promoter in proximity to HDAC1, HDAC2, and Sp1 to transcriptionally repress ELOVL4 expression; ELOVL4 positively regulates neuronal differentiation and lipid droplet accumulation in neuroblastoma cells; MYCN silencing increases FA34:6 production.","method":"ChIP for MYCN at ELOVL4 promoter, MYCN siRNA knockdown with FA34:6 metabolite measurement, neuronal differentiation assays in neuroblastoma cells","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ChIP demonstrating transcription factor binding, functional silencing with metabolite readout, single lab","pmids":["34333551"],"is_preprint":false},{"year":2025,"finding":"Contact cooling of wounded skin to 20°C induces ELOVL4 expression in injured epidermis; ELOVL4-derived DHA and EPA dampen TNFα and other pro-inflammatory cytokine expression, promoting the transition from inflammation to the proliferation phase of wound healing.","method":"Skin injury model, skin organoids, bulk/single-cell RNA-seq, spatial transcriptomics, in vivo ELOVL4 perturbation, cytokine measurement, wound healing rate quantification","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo functional perturbation with mechanistic cytokine readout, multiple transcriptomic methods, single lab","pmids":["40083712"],"is_preprint":false},{"year":2026,"finding":"Testis-specific knockout of Elovl4 (Stra8-Cre) abolishes VLC-PUFA (>C26) synthesis in testes, causes abnormal spermatogenesis, reduced sperm count, sperm malformation, markedly decreased sperm motility with altered Defbs gene family expression, and reduced male fertility.","method":"Testis-specific Elovl4 conditional KO mice, lipid analysis by GC-MS, sperm motility and morphology assessment, RT-PCR/qPCR/Western blot/immunohistochemistry for Defbs expression","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Strong — conditional KO with direct biochemical (lipid) and functional (fertility) readouts, multiple orthogonal methods","pmids":["41495266"],"is_preprint":false}],"current_model":"ELOVL4 is an ER-resident fatty acid elongase that catalyzes the rate-limiting condensation step in the biosynthesis of very long chain saturated fatty acids (VLC-SFAs, ≥C28) and very long chain polyunsaturated fatty acids (VLC-PUFAs, C28–C38), using C26 FAs and C20–C22 PUFAs as preferred substrates; its active site histidines and ER localization are both required for activity, and it functions in photoreceptors (producing VLC-PUFAs enriched in outer segment phosphatidylcholines), neurons (producing VLC-SFAs enriched in synaptic vesicles that regulate presynaptic neurotransmitter release kinetics and cerebellar synaptic plasticity), skin (producing acylceramides essential for epidermal permeability barrier), retinal endothelium (producing ceramides that stabilize tight junctions), testes (producing VLC-PUFAs required for spermatogenesis and male fertility), and meibomian glands; disease-causing truncation mutations lose the C-terminal dilysine ER-retention signal, causing mislocalization to aggresomes and dominant negative sequestration of wild-type ELOVL4, while SCA34-causing missense mutations (e.g., L168F, W246G) selectively impair VLC-SFA but not VLC-PUFA biosynthesis, explaining their distinct tissue-specific neurological rather than retinal phenotype."},"narrative":{"mechanistic_narrative":"ELOVL4 is an endoplasmic reticulum-resident fatty acid elongase that catalyzes the condensation step in the biosynthesis of very long chain fatty acids, generating both very long chain saturated fatty acids (VLC-SFAs, ≥C28) from C24:0–C26:0 precursors and very long chain polyunsaturated fatty acids (VLC-PUFAs, C28–C38) from C20–C22 PUFAs such as EPA, with preferential elongation of 20:5n3 over DHA [PMID:18728184, PMID:22158834]. Its catalytic activity depends on conserved active-site histidine residues and on ER localization, but not on N-glycosylation [PMID:24569140]; ER retention is enforced by a C-terminal dilysine motif [PMID:15028284]. These elongation products serve distinct tissue programs: in skin ELOVL4 is the sole enzyme producing omega-O-acylceramides and ≥C28 free fatty acids required for the epidermal permeability barrier, and its loss causes neonatal-lethal barrier failure rescued by epidermis-specific re-expression [PMID:17208947, PMID:17311087, PMID:21429867]; in photoreceptors it supplies VLC-PUFAs enriched in outer-segment phosphatidylcholines [PMID:22199362]; in neurons VLC-SFAs in synaptic vesicles set presynaptic neurotransmitter release kinetics and cerebellar synaptic plasticity [PMID:29168048, PMID:34227061]; in retinal endothelium VLC-ceramides stabilize tight junctions [PMID:29362226]; and in testis VLC-PUFAs are required for spermatogenesis and male fertility [PMID:41495266]. ELOVL4 was first identified through a 5-bp deletion causing autosomal dominant Stargardt-like macular dystrophy (STGD3) [PMID:11138005]; this and other C-terminal truncations delete the dilysine signal, mislocalize the protein to aggresome-like inclusions, and sequester wild-type ELOVL4, defining a dominant-negative mechanism rather than haploinsufficiency [PMID:15028284, PMID:16036915, PMID:16877435, PMID:17254625, PMID:23509295]. By contrast, SCA34-causing missense mutations (e.g., L168F, W246G) selectively impair VLC-SFA but largely spare VLC-PUFA biosynthesis, accounting for their neurological rather than retinal presentation [PMID:32780351, PMID:36464075, PMID:36748939].","teleology":[{"year":2001,"claim":"Established ELOVL4 as a photoreceptor-expressed gene whose truncation causes a dominant macular dystrophy, linking a putative elongase to inherited retinal disease.","evidence":"Recombination mapping and sequencing of STGD3 families with homology analysis to yeast VLCFA enzymes","pmids":["11138005"],"confidence":"High","gaps":["No direct enzymatic activity demonstrated","Substrates and products unknown"]},{"year":2004,"claim":"Defined the wild-type ER localization of ELOVL4 via a C-terminal dilysine motif and showed disease truncations mislocalize, framing a localization-based pathology.","evidence":"Immunofluorescence/immuno-EM in human photoreceptors and transfected COS-7/CHO/NIH-3T3/HEK293 cells, organelle markers, TUNEL","pmids":["15028284","15073583","15557430"],"confidence":"High","gaps":["Whether mislocalization alone or loss of catalytic product drives disease unresolved","No enzymatic activity tested"]},{"year":2005,"claim":"Demonstrated a dominant-negative mechanism: truncated ELOVL4 forms aggresomes, binds wild-type protein, recruits it out of the ER, and triggers the UPR.","evidence":"Co-IP, FRET, 2D gel, sucrose gradient, BiP/CHOP Western blot in COS-7/HEK293 cells","pmids":["16036915","16163264","16145543"],"confidence":"High","gaps":["Cell-culture overexpression may not reflect photoreceptor context","Did not yet quantify loss of catalytic output"]},{"year":2007,"claim":"Genetic loss-of-function in mice established ELOVL4 as essential for skin VLC-FA/acylceramide synthesis and proved haploinsufficiency is not the STGD3 mechanism.","evidence":"Knock-in 5-bp deletion and knockout mice, epidermal lipidomics, EM of lamellar bodies, transepidermal water loss, ERG of heterozygotes","pmids":["17208947","17311087","17304340","16877435","17254625"],"confidence":"High","gaps":["Neonatal lethality precluded study of retinal and neuronal roles","Precise C26 substrate-to-product step not directly assayed in vitro"]},{"year":2008,"claim":"Provided the first direct biochemical evidence that ELOVL4 is the elongase, defining both VLC-SFA and VLC-PUFA product spectra.","evidence":"Adenoviral gain-of-function expression with labeled FA precursors and FA profiling in cardiomyocytes and ARPE-19 cells","pmids":["18728184"],"confidence":"High","gaps":["Did not resolve which condensation residues are catalytic","Substrate preference among PUFAs not yet ranked"]},{"year":2011,"claim":"Refined substrate selectivity and defined the photoreceptor lipid product, while excluding ELOVL4 from DHA synthesis.","evidence":"Photoreceptor conditional KO with HPLC-MS lipidomics; ELOVL4 expression with individual substrate supplementation and GC-MS; siRNA in 661W cells","pmids":["22199362","22158834","20238022"],"confidence":"High","gaps":["Functional consequence of VLC-PUFA loss in vision not yet dissected from mutant toxicity"]},{"year":2013,"claim":"Genetic epistasis separated VLC-PUFA depletion from mutant-protein toxicity, and enzymology confirmed the truncated mutant is catalytically dead and dominant-negative.","evidence":"Rod/cone conditional KO vs STGD3 transgenic mice with ERG/optomotor; cell-free microsome elongase assays with co-expression","pmids":["23479632","23509295"],"confidence":"High","gaps":["Why VLC-PUFA depletion alone is tolerated in mouse rods left open","Identity of the toxic species in transgenic retina unresolved"]},{"year":2014,"claim":"Established the catalytic and localization requirements of ELOVL4 and extended its roles to meibomian gland function.","evidence":"Active-site histidine, ER-retention, and glycosylation mutants with elongation assays; immunohistochemistry and ocular phenotyping of Stgd3 mice; in vivo Xenopus rod localization","pmids":["24569140","24677106","24833735"],"confidence":"High","gaps":["In vivo Xenopus data did not reproduce wild-type sequestration seen in cell culture","Structural basis of substrate selection unknown"]},{"year":2017,"claim":"Identified VLC-SFAs as regulators of presynaptic vesicle release, explaining neurological phenotype through synaptic dysfunction.","evidence":"Skin-rescued homozygous STGD3 mice, hippocampal FM1-43 release assay, electrophysiology, VLC-SFA supplementation rescue","pmids":["29168048"],"confidence":"High","gaps":["Molecular target through which VLC-SFAs alter release kinetics unknown"]},{"year":2018,"claim":"Extended ELOVL4 products to retinal endothelial tight-junction stabilization and germ-cell sphingolipid synthesis.","evidence":"ELOVL4 overexpression/AAV in retinal endothelium with permeability and TJ readouts; radiolabeled arachidonate elongation in isolated testicular germ cells","pmids":["29362226","29724783"],"confidence":"Medium","gaps":["Mechanism by which VLC-ceramides stabilize tight junctions not defined","Germ-cell findings single-lab, primary-cell based"]},{"year":2020,"claim":"Defined the SCA34 mechanism: missense mutations selectively impair VLC-SFA synthesis, accounting for tissue-specific neurological pathology.","evidence":"W246G knock-in rat with GC-MS lipid analysis, ERG, OCT, histology; patient fibroblast localization","pmids":["32780351","32211516"],"confidence":"High","gaps":["Patient-fibroblast localization is single-method, low-confidence","Link between VLC-SFA loss and retinal function decrement not mechanistic"]},{"year":2021,"claim":"Demonstrated that ELOVL4 VLC-SFAs are required for cerebellar synaptic plasticity and that ELOVL4 is transcriptionally repressed by MYCN in neuroblastoma.","evidence":"Cerebellar slice LTP/LTD recordings and rotarod in W246G rats; MYCN ChIP at ELOVL4 promoter with siRNA and metabolite/differentiation assays","pmids":["34227061","34333551","33556440"],"confidence":"High","gaps":["How VLC-SFAs influence Purkinje synapse plasticity at molecular level unknown","Functional consequence of MYCN-driven repression in tumors not fully resolved"]},{"year":2023,"claim":"Resolved structural and biochemical basis of SCA34 variant heterogeneity and placed ELOVL4 in an epidermal tumor-suppressor axis and wound-healing program.","evidence":"Cell-based PC elongation assays for multiple variants plus structural modeling and knock-in ES cells; detailed patch-clamp in W246G rats; NOTCH-RIPK4-IRF6/CRISPR tumor models; cooling-induced wound-healing model","pmids":["36464075","36748939","36465696","37491316","37568198","36765696","40083712"],"confidence":"High","gaps":["Direct enzyme structure not solved (modeling only)","Mechanism by which ELOVL4 loss permits squamous carcinoma not fully defined"]},{"year":2026,"claim":"Established a required role for ELOVL4 VLC-PUFAs in spermatogenesis and male fertility.","evidence":"Testis-specific conditional KO mice with GC-MS lipidomics, sperm phenotyping, and Defbs expression analysis","pmids":["41495266"],"confidence":"High","gaps":["How VLC-PUFA loss alters Defbs expression and sperm motility mechanistically unknown"]},{"year":null,"claim":"The molecular targets through which ELOVL4-derived VLC lipids act on synaptic release machinery, tight junctions, and sperm function remain undefined, and no experimental structure of the enzyme exists.","evidence":"Not yet addressed in the available corpus","pmids":[],"confidence":"Low","gaps":["No experimentally determined ELOVL4 structure","Lipid-effector interactions at synapses and junctions unmapped","Regulation of ELOVL4 expression across tissues incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[12,15,18,28]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,2,18]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[12,15,18]}],"complexes":[],"partners":["ELOVL4","ELOVL1","ELOVL2","ELOVL3","ELOVL5","ELOVL6","ELOVL7"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9GZR5","full_name":"Very long chain fatty acid elongase 4","aliases":["3-keto acyl-CoA synthase ELOVL4","ELOVL fatty acid elongase 4","ELOVL FA elongase 4","Elongation of very long chain fatty acids protein 4","Very long chain 3-ketoacyl-CoA synthase 4","Very long chain 3-oxoacyl-CoA synthase 4"],"length_aa":314,"mass_kda":36.8,"function":"Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that catalyzes the synthesis of very long chain saturated (VLC-SFA) and polyunsaturated (PUFA) fatty acids that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May play a critical role in early brain and skin development","subcellular_location":"Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q9GZR5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ELOVL4","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ELOVL4","total_profiled":1310},"omim":[{"mim_id":"614457","title":"ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ISQMR","url":"https://www.omim.org/entry/614457"},{"mim_id":"611313","title":"ARMS2 GENE; ARMS2","url":"https://www.omim.org/entry/611313"},{"mim_id":"610698","title":"MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4","url":"https://www.omim.org/entry/610698"},{"mim_id":"607772","title":"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 1; PLEKHA1","url":"https://www.omim.org/entry/607772"},{"mim_id":"605512","title":"ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 4; ELOVL4","url":"https://www.omim.org/entry/605512"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":98.1},{"tissue":"retina","ntpm":163.6}],"url":"https://www.proteinatlas.org/search/ELOVL4"},"hgnc":{"alias_symbol":["CT118"],"prev_symbol":["STGD2","STGD3","SCA34"]},"alphafold":{"accession":"Q9GZR5","domains":[{"cath_id":"-","chopping":"76-271","consensus_level":"high","plddt":91.8241,"start":76,"end":271}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZR5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZR5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZR5-F1-predicted_aligned_error_v6.png","plddt_mean":83.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ELOVL4","jax_strain_url":"https://www.jax.org/strain/search?query=ELOVL4"},"sequence":{"accession":"Q9GZR5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9GZR5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9GZR5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZR5"}},"corpus_meta":[{"pmid":"11138005","id":"PMC_11138005","title":"A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy.","date":"2001","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11138005","citation_count":365,"is_preprint":false},{"pmid":"18728184","id":"PMC_18728184","title":"Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18728184","citation_count":224,"is_preprint":false},{"pmid":"17208947","id":"PMC_17208947","title":"Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17208947","citation_count":214,"is_preprint":false},{"pmid":"22100072","id":"PMC_22100072","title":"Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia.","date":"2011","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22100072","citation_count":156,"is_preprint":false},{"pmid":"15749821","id":"PMC_15749821","title":"Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15749821","citation_count":152,"is_preprint":false},{"pmid":"17311087","id":"PMC_17311087","title":"Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice.","date":"2007","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17311087","citation_count":135,"is_preprint":false},{"pmid":"11726641","id":"PMC_11726641","title":"Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene.","date":"2001","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11726641","citation_count":134,"is_preprint":false},{"pmid":"20299492","id":"PMC_20299492","title":"Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/20299492","citation_count":132,"is_preprint":false},{"pmid":"17304340","id":"PMC_17304340","title":"Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival.","date":"2007","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17304340","citation_count":121,"is_preprint":false},{"pmid":"19875612","id":"PMC_19875612","title":"Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4.","date":"2009","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/19875612","citation_count":114,"is_preprint":false},{"pmid":"24566826","id":"PMC_24566826","title":"Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia.","date":"2014","source":"JAMA neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24566826","citation_count":100,"is_preprint":false},{"pmid":"31616255","id":"PMC_31616255","title":"Novel Cellular Functions of Very Long Chain-Fatty Acids: Insight From ELOVL4 Mutations.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31616255","citation_count":90,"is_preprint":false},{"pmid":"20601113","id":"PMC_20601113","title":"Expression and role of Elovl4 elongases in biosynthesis of very long-chain fatty acids during zebrafish Danio rerio early embryonic development.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20601113","citation_count":82,"is_preprint":false},{"pmid":"15028285","id":"PMC_15028285","title":"Characterization of mouse orthologue of ELOVL4: genomic organization and spatial and temporal expression.","date":"2004","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15028285","citation_count":79,"is_preprint":false},{"pmid":"15557430","id":"PMC_15557430","title":"A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy.","date":"2004","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15557430","citation_count":78,"is_preprint":false},{"pmid":"22199362","id":"PMC_22199362","title":"Essential role of ELOVL4 protein in very long chain fatty acid synthesis and retinal function.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22199362","citation_count":77,"is_preprint":false},{"pmid":"16036915","id":"PMC_16036915","title":"Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16036915","citation_count":75,"is_preprint":false},{"pmid":"26010696","id":"PMC_26010696","title":"A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia: A Broadened Spectrum of SCA34.","date":"2015","source":"JAMA neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26010696","citation_count":70,"is_preprint":false},{"pmid":"30982505","id":"PMC_30982505","title":"ELOVL4: Very long-chain fatty acids serve an eclectic role in mammalian health and function.","date":"2018","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/30982505","citation_count":69,"is_preprint":false},{"pmid":"21377536","id":"PMC_21377536","title":"Biosynthesis of very long-chain fatty acids (C>24) in Atlantic salmon: cloning, functional characterisation, and tissue distribution of an Elovl4 elongase.","date":"2011","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21377536","citation_count":64,"is_preprint":false},{"pmid":"33556440","id":"PMC_33556440","title":"Very long chain fatty acid-containing lipids: a decade of novel insights from the study of ELOVL4.","date":"2021","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/33556440","citation_count":62,"is_preprint":false},{"pmid":"31316480","id":"PMC_31316480","title":"Taxonomy and Broad-Spectrum Antifungal Activity of Streptomyces sp. SCA3-4 Isolated From Rhizosphere Soil of Opuntia stricta.","date":"2019","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31316480","citation_count":58,"is_preprint":false},{"pmid":"17983602","id":"PMC_17983602","title":"A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32-C36 acyl phosphatidylcholines.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17983602","citation_count":57,"is_preprint":false},{"pmid":"22158834","id":"PMC_22158834","title":"ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3.","date":"2011","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22158834","citation_count":55,"is_preprint":false},{"pmid":"16145543","id":"PMC_16145543","title":"Loss of ER retention and sequestration of the wild-type ELOVL4 by Stargardt disease dominant negative mutants.","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/16145543","citation_count":55,"is_preprint":false},{"pmid":"16163264","id":"PMC_16163264","title":"Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes.","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/16163264","citation_count":54,"is_preprint":false},{"pmid":"17003453","id":"PMC_17003453","title":"Elovl4 5-bp-deletion knock-in mice develop progressive photoreceptor degeneration.","date":"2006","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/17003453","citation_count":53,"is_preprint":false},{"pmid":"15028284","id":"PMC_15028284","title":"Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.","date":"2004","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15028284","citation_count":52,"is_preprint":false},{"pmid":"23479632","id":"PMC_23479632","title":"Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23479632","citation_count":48,"is_preprint":false},{"pmid":"21873315","id":"PMC_21873315","title":"Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration.","date":"2011","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/21873315","citation_count":48,"is_preprint":false},{"pmid":"24677106","id":"PMC_24677106","title":"A role for ELOVL4 in the mouse meibomian gland and sebocyte cell biology.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24677106","citation_count":46,"is_preprint":false},{"pmid":"29417145","id":"PMC_29417145","title":"Stargardt Phenotype Associated With Two ELOVL4 Promoter Variants and ELOVL4 Downregulation: New Possible Perspective to Etiopathogenesis?","date":"2018","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/29417145","citation_count":46,"is_preprint":false},{"pmid":"26112824","id":"PMC_26112824","title":"Polyunsaturated fatty acid metabolism in a marine teleost, Nibe croaker Nibea mitsukurii: Functional characterization of Fads2 desaturase and Elovl5 and Elovl4 elongases.","date":"2015","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26112824","citation_count":43,"is_preprint":false},{"pmid":"29362226","id":"PMC_29362226","title":"ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.","date":"2018","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/29362226","citation_count":41,"is_preprint":false},{"pmid":"23509295","id":"PMC_23509295","title":"Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23509295","citation_count":40,"is_preprint":false},{"pmid":"16877435","id":"PMC_16877435","title":"Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.","date":"2006","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/16877435","citation_count":40,"is_preprint":false},{"pmid":"12847421","id":"PMC_12847421","title":"Elovl4 mRNA distribution in the developing mouse retina and phylogenetic conservation of Elovl4 genes.","date":"2003","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/12847421","citation_count":39,"is_preprint":false},{"pmid":"19682985","id":"PMC_19682985","title":"Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscin.","date":"2009","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/19682985","citation_count":37,"is_preprint":false},{"pmid":"29168048","id":"PMC_29168048","title":"Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency.","date":"2017","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/29168048","citation_count":37,"is_preprint":false},{"pmid":"15073583","id":"PMC_15073583","title":"Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability.","date":"2004","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/15073583","citation_count":36,"is_preprint":false},{"pmid":"11803489","id":"PMC_11803489","title":"Evaluation of the ELOVL4 gene in patients with age-related macular degeneration.","date":"2001","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11803489","citation_count":35,"is_preprint":false},{"pmid":"19536303","id":"PMC_19536303","title":"DHA does not protect ELOVL4 transgenic mice from retinal degeneration.","date":"2009","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/19536303","citation_count":33,"is_preprint":false},{"pmid":"16476896","id":"PMC_16476896","title":"Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation.","date":"2006","source":"Archives of ophthalmology (Chicago, Ill. : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/16476896","citation_count":32,"is_preprint":false},{"pmid":"21429867","id":"PMC_21429867","title":"Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice.","date":"2011","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/21429867","citation_count":31,"is_preprint":false},{"pmid":"31750392","id":"PMC_31750392","title":"A family with spinocerebellar ataxia and retinitis pigmentosa attributed to an ELOVL4 mutation.","date":"2019","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31750392","citation_count":31,"is_preprint":false},{"pmid":"28507511","id":"PMC_28507511","title":"Distribution of ELOVL4 in the Developing and Adult Mouse Brain.","date":"2017","source":"Frontiers in neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/28507511","citation_count":30,"is_preprint":false},{"pmid":"24571530","id":"PMC_24571530","title":"A novel recessive mutation in the gene ELOVL4 causes a neuro-ichthyotic disorder with variable expressivity.","date":"2014","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24571530","citation_count":30,"is_preprint":false},{"pmid":"32211516","id":"PMC_32211516","title":"Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA34.","date":"2020","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32211516","citation_count":27,"is_preprint":false},{"pmid":"17254625","id":"PMC_17254625","title":"Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice.","date":"2007","source":"Vision research","url":"https://pubmed.ncbi.nlm.nih.gov/17254625","citation_count":26,"is_preprint":false},{"pmid":"26427403","id":"PMC_26427403","title":"Different Mutations in ELOVL4 Affect Very Long Chain Fatty Acid Biosynthesis to Cause Variable Neurological Disorders in Humans.","date":"2016","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/26427403","citation_count":25,"is_preprint":false},{"pmid":"21139992","id":"PMC_21139992","title":"Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.","date":"2010","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/21139992","citation_count":24,"is_preprint":false},{"pmid":"24569140","id":"PMC_24569140","title":"Endoplasmic reticulum microenvironment and conserved histidines govern ELOVL4 fatty acid elongase activity.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/24569140","citation_count":24,"is_preprint":false},{"pmid":"28668330","id":"PMC_28668330","title":"Molecular and functional characterisation of two elovl4 elongases involved in the biosynthesis of very long-chain (>C24) polyunsaturated fatty acids in black seabream Acanthopagrus schlegelii.","date":"2017","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28668330","citation_count":24,"is_preprint":false},{"pmid":"34725421","id":"PMC_34725421","title":"Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34725421","citation_count":20,"is_preprint":false},{"pmid":"24833735","id":"PMC_24833735","title":"Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24833735","citation_count":19,"is_preprint":false},{"pmid":"22948568","id":"PMC_22948568","title":"Evaluation of the ELOVL4, PRPH2 and ABCA4 genes in patients with Stargardt macular degeneration.","date":"2012","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/22948568","citation_count":19,"is_preprint":false},{"pmid":"36464075","id":"PMC_36464075","title":"ELOVL4 Mutations That Cause Spinocerebellar Ataxia-34 Differentially Alter Very Long Chain Fatty Acid Biosynthesis.","date":"2022","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/36464075","citation_count":18,"is_preprint":false},{"pmid":"29724783","id":"PMC_29724783","title":"Elovl4 and Fa2h expression during rat spermatogenesis: a link to the very-long-chain PUFAs typical of germ cell sphingolipids.","date":"2018","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/29724783","citation_count":18,"is_preprint":false},{"pmid":"32780351","id":"PMC_32780351","title":"The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration.","date":"2020","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/32780351","citation_count":17,"is_preprint":false},{"pmid":"34333551","id":"PMC_34333551","title":"The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34333551","citation_count":17,"is_preprint":false},{"pmid":"32186869","id":"PMC_32186869","title":"Two Elongases, Elovl4 and Elovl6, Fulfill the Elongation Routes of the LC-PUFA Biosynthesis Pathway in the Orange Mud Crab (Scylla olivacea).","date":"2020","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32186869","citation_count":17,"is_preprint":false},{"pmid":"36765696","id":"PMC_36765696","title":"The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36765696","citation_count":16,"is_preprint":false},{"pmid":"34227061","id":"PMC_34227061","title":"W246G Mutant ELOVL4 Impairs Synaptic Plasticity in Parallel and Climbing Fibers and Causes Motor Defects in a Rat Model of SCA34.","date":"2021","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/34227061","citation_count":16,"is_preprint":false},{"pmid":"29377748","id":"PMC_29377748","title":"Long-term follow-up of autosomal dominant Stargardt macular dystrophy (STGD3) subjects enrolled in a fish oil supplement interventional trial.","date":"2018","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29377748","citation_count":16,"is_preprint":false},{"pmid":"31669375","id":"PMC_31669375","title":"Molecular and functional characterisation of a putative elovl4 gene and its expression in response to dietary fatty acid profile in Atlantic bluefin tuna (Thunnus thynnus).","date":"2019","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31669375","citation_count":16,"is_preprint":false},{"pmid":"29287723","id":"PMC_29287723","title":"Elovl4 can effectively elongate C18 polyunsaturated fatty acids in loach Misgurnus anguillicaudatus.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29287723","citation_count":16,"is_preprint":false},{"pmid":"28856549","id":"PMC_28856549","title":"Elongation of very Long-Chain (>C24) Fatty Acids in Clarias gariepinus: Cloning, Functional Characterization and Tissue Expression of elovl4 Elongases.","date":"2017","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/28856549","citation_count":16,"is_preprint":false},{"pmid":"29277642","id":"PMC_29277642","title":"Cloning, tissue distribution and nutritional regulation of a fatty acyl Elovl4-like elongase in mud crab, Scylla paramamosain (Estampador, 1949).","date":"2017","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29277642","citation_count":16,"is_preprint":false},{"pmid":"24664730","id":"PMC_24664730","title":"Dominant Stargardt Macular Dystrophy (STGD3) and ELOVL4.","date":"2014","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/24664730","citation_count":15,"is_preprint":false},{"pmid":"29654292","id":"PMC_29654292","title":"Photoreceptor-induced RPE phagolysosomal maturation defects in Stargardt-like Maculopathy (STGD3).","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29654292","citation_count":15,"is_preprint":false},{"pmid":"19933199","id":"PMC_19933199","title":"Inner retina remodeling in a mouse model of stargardt-like macular dystrophy (STGD3).","date":"2009","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/19933199","citation_count":15,"is_preprint":false},{"pmid":"26529045","id":"PMC_26529045","title":"Early Onset Ultrastructural and Functional Defects in RPE and Photoreceptors of a Stargardt-Like Macular Dystrophy (STGD3) Transgenic Mouse Model.","date":"2015","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/26529045","citation_count":14,"is_preprint":false},{"pmid":"20238022","id":"PMC_20238022","title":"Role of Elovl4 protein in the biosynthesis of docosahexaenoic acid.","date":"2010","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/20238022","citation_count":14,"is_preprint":false},{"pmid":"12806887","id":"PMC_12806887","title":"Molecular cloning of ELOVL4 gene from cynomolgus monkey (Macaca fascicularis).","date":"2003","source":"Experimental animals","url":"https://pubmed.ncbi.nlm.nih.gov/12806887","citation_count":14,"is_preprint":false},{"pmid":"24334447","id":"PMC_24334447","title":"Long-term retinal cone survival and delayed alteration of the cone mosaic in a transgenic mouse model of stargardt-like dystrophy (STGD3).","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24334447","citation_count":14,"is_preprint":false},{"pmid":"32429178","id":"PMC_32429178","title":"Molecular and Functional Characterization of Elovl4 Genes in Sparus aurata and Solea senegalensis Pointing to a Critical Role in Very Long-Chain (>C24) Fatty Acid Synthesis during Early Neural Development of Fish.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32429178","citation_count":13,"is_preprint":false},{"pmid":"31958500","id":"PMC_31958500","title":"Cloning and functional characterization of an elovl4-like gene involved in the biosynthesis of long-chain polyunsaturated fatty acids in the swimming crab Portunus trituberculatus.","date":"2020","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31958500","citation_count":13,"is_preprint":false},{"pmid":"37491316","id":"PMC_37491316","title":"Synapse-Specific Defects in Synaptic Transmission in the Cerebellum of W246G Mutant ELOVL4 Rats-a Model of Human SCA34.","date":"2023","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37491316","citation_count":11,"is_preprint":false},{"pmid":"33652762","id":"PMC_33652762","title":"Two Italian Patients with ELOVL4-Related Neuro-Ichthyosis:  Expanding the Genotypic and Phenotypic Spectrum and Ultrastructural Characterization.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/33652762","citation_count":11,"is_preprint":false},{"pmid":"24644051","id":"PMC_24644051","title":"In vivo effect of mutant ELOVL4 on the expression and function of wild-type ELOVL4.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24644051","citation_count":10,"is_preprint":false},{"pmid":"34689836","id":"PMC_34689836","title":"Neuropathology of SCA34 showing widespread oligodendroglial pathology with vacuolar white matter degeneration: a case study.","date":"2021","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/34689836","citation_count":10,"is_preprint":false},{"pmid":"12592226","id":"PMC_12592226","title":"Evaluation of the ELOVL4 gene in patients with autosomal recessive retinitis pigmentosa and Leber congenital amaurosis.","date":"2003","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/12592226","citation_count":9,"is_preprint":false},{"pmid":"24664752","id":"PMC_24664752","title":"Biosynthesis of very long-chain polyunsaturated fatty acids in hepatocytes expressing ELOVL4.","date":"2014","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/24664752","citation_count":8,"is_preprint":false},{"pmid":"37568198","id":"PMC_37568198","title":"A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.","date":"2023","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/37568198","citation_count":7,"is_preprint":false},{"pmid":"37184663","id":"PMC_37184663","title":"SCA34 caused by ELOVL4 L168F mutation is a lysosomal lipid storage disease sharing pathology features with neuronal ceroid lipofuscinosis and peroxisomal disorders.","date":"2023","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/37184663","citation_count":7,"is_preprint":false},{"pmid":"29293603","id":"PMC_29293603","title":"Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29293603","citation_count":7,"is_preprint":false},{"pmid":"36748939","id":"PMC_36748939","title":"Incomplete Elongation of Ultra-long-chain Polyunsaturated Acyl-CoAs by the Fatty Acid Elongase ELOVL4 in Spinocerebellar Ataxia Type 34.","date":"2023","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/36748939","citation_count":6,"is_preprint":false},{"pmid":"37592902","id":"PMC_37592902","title":"Expanding the allelic spectrum of ELOVL4-related autosomal recessive neuro-ichthyosis.","date":"2023","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37592902","citation_count":6,"is_preprint":false},{"pmid":"12967813","id":"PMC_12967813","title":"Autosomal dominant Stargardt-like macular dystrophy: identification of a new family with a mutation in the ELOVL4 gene.","date":"2003","source":"American journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/12967813","citation_count":5,"is_preprint":false},{"pmid":"16364203","id":"PMC_16364203","title":"Evaluation of the ELOVL4 gene in a Chinese family with autosomal dominant STGD3-like macular dystrophy.","date":"2005","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16364203","citation_count":4,"is_preprint":false},{"pmid":"40083712","id":"PMC_40083712","title":"Contact Cooling-Induced ELOVL4 Enhances Skin Wound Healing by Promoting the Inflammation-to-Proliferation Phase Transition.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40083712","citation_count":3,"is_preprint":false},{"pmid":"38850484","id":"PMC_38850484","title":"The Spinocerebellar Ataxia 34-Causing W246G ELOVL4 Mutation Does Not Alter Cerebellar Neuron Populations in a Rat Model.","date":"2024","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/38850484","citation_count":1,"is_preprint":false},{"pmid":"36002420","id":"PMC_36002420","title":"[Construction of a testis Elovl4 gene knockout mouse model based on Cre/loxP system].","date":"2022","source":"Sheng wu gong cheng xue bao = Chinese journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36002420","citation_count":1,"is_preprint":false},{"pmid":"20388345","id":"PMC_20388345","title":"[Association of M299V variant in ELOVL4 gene with exudative age-related macular degeneration in a Chinese population].","date":"2010","source":"[Zhonghua yan ke za zhi] Chinese journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/20388345","citation_count":1,"is_preprint":false},{"pmid":"42256737","id":"PMC_42256737","title":"Correlation and regression analysis of the KRT27 and ELOVL4 genes in cashmere fineness and other production performances in Liaoning cashmere goats.","date":"2025","source":"Archives animal breeding","url":"https://pubmed.ncbi.nlm.nih.gov/42256737","citation_count":0,"is_preprint":false},{"pmid":"32916248","id":"PMC_32916248","title":"Functional characterization, tissue distribution and nutritional regulation of the Elovl4 gene in golden pompano, Trachinotus ovatus (Linnaeus, 1758).","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32916248","citation_count":0,"is_preprint":false},{"pmid":"41495266","id":"PMC_41495266","title":"Testis-specific knockout of Elovl4 reduces sperm motility and fertility in male mice.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41495266","citation_count":0,"is_preprint":false},{"pmid":"36623811","id":"PMC_36623811","title":"Acral collodion membrane associated with ichthyosis due to a heterozygous pathogenic variant of ELOVL4 gene.","date":"2023","source":"Pediatric dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/36623811","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.15.682296","title":"Establishment of spinocerebellar ataxia type 34 model mice accompanied by early glial activation and degeneration of cerebellar neurons","date":"2025-10-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.15.682296","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54985,"output_tokens":9205,"usd":0.151515,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19185,"output_tokens":4515,"usd":0.1044,"stage2_stop_reason":"end_turn"},"total_usd":0.255915,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"ELOVL4 encodes a retinal photoreceptor-specific protein with homology to yeast proteins involved in biosynthesis of very long chain fatty acids; a 5-bp deletion in exon 6 causes protein truncation and is associated with autosomal dominant Stargardt-like macular dystrophy (STGD3).\",\n      \"method\": \"Recombination breakpoint mapping, direct sequencing, bioinformatic homology analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic mapping plus sequencing, replicated across multiple families and independently confirmed by multiple subsequent studies\",\n      \"pmids\": [\"11138005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Wild-type ELOVL4 localizes predominantly to the endoplasmic reticulum (ER) in COS-7 and CHO cells, dependent on a C-terminal dilysine (KXKXX) ER retention/retrieval motif; disease-associated truncation mutants lose ER localization and are redirected to the Golgi compartment.\",\n      \"method\": \"Immunofluorescence with organelle-specific markers, immunoelectron microscopy in human photoreceptors, transfection of COS-7 and CHO cells\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal localization methods, validated in human photoreceptors, replicated across multiple independent studies\",\n      \"pmids\": [\"15028284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Wild-type ELOVL4 localizes to the ER and not to mitochondria, peroxisomes, or Golgi; mutant ELOVL4 (lacking ER retention signal) mislocalizes to cytoplasmic aggregates and induces apoptotic cell death in transfected cells.\",\n      \"method\": \"Confocal microscopy with organelle-specific markers (ER, mitochondria, peroxisomes, Golgi), TUNEL staining, Western blot in NIH-3T3 and HEK293 cells\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple organelle markers used, functional apoptosis readout, single lab\",\n      \"pmids\": [\"15073583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"A novel Y270X truncation mutation in ELOVL4 causes mislocalization of the mutant protein away from the ER in NIH-3T3 and HEK293 cells, consistent with loss of the ER retention signal.\",\n      \"method\": \"Transfection with EGFP fusion proteins, confocal microscopy with ER marker (pDsRed2-ER), Western blot\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, fluorescence localization, consistent with other reports\",\n      \"pmids\": [\"15557430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Disease-associated C-terminal truncation mutants of ELOVL4 accumulate in aggresome-like juxtanuclear inclusions; wild-type ELOVL4 co-immunoprecipitates with mutant ELOVL4 and is recruited into these aggresomes, establishing a dominant negative mechanism that alters wild-type protein subcellular localization.\",\n      \"method\": \"Immunofluorescence, co-immunoprecipitation, immunoaffinity chromatography in COS-7 and HEK293T cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP plus immunofluorescence colocalization, replicated by multiple independent groups\",\n      \"pmids\": [\"16036915\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ELOVL4 5-bp deletion mutant interacts with wild-type ELOVL4 and recruits it into perinuclear aggresome-like inclusions; interaction demonstrated by 2D gel electrophoresis and FRET analysis in COS-7 cells.\",\n      \"method\": \"Immunocytochemistry, 2D gel electrophoresis, FRET analysis, Western blot in COS-7 cells\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRET directly demonstrates protein-protein interaction, two orthogonal methods, single lab\",\n      \"pmids\": [\"16163264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ELOVL4 truncation mutants cause loss of ER retention and sequestration of wild-type ELOVL4 into non-ER aggregates; mutant expression induces the unfolded protein response (UPR) as evidenced by upregulation of BiP and CHOP.\",\n      \"method\": \"Fluorescence microscopy, co-immunoprecipitation, sucrose gradient centrifugation with immunodetection, Western blot for BiP and CHOP in HEK293 and COS cells\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods, UPR markers measured, single lab\",\n      \"pmids\": [\"16145543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ELOVL4 is required for synthesis of very long chain fatty acids (≥C28) in skin; homozygous loss-of-function (knock-in 5-bp deletion) in mice depletes C28+ ceramides and free fatty acids, eliminates epidermal omega-O-acylceramides essential for stratum corneum lamellar membranes, and causes lethal epidermal permeability barrier failure.\",\n      \"method\": \"Knock-in mouse model, lipid analysis of epidermis, electron microscopy of lamellar bodies, histopathology, transepidermal water loss measurements\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic loss-of-function with defined biochemical (lipid depletion) and structural phenotype, independently replicated by multiple groups\",\n      \"pmids\": [\"17208947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Homozygous knockout of Elovl4 in mice depletes epidermal ceramides containing omega-hydroxy VLC-FAs (≥C28) and causes accumulation of C26-ceramides, implicating C26 fatty acids as substrates for ELOVL4; skin water permeability barrier failure leads to neonatal death.\",\n      \"method\": \"Elovl4 knockout mice, lipidomic analysis of ceramide fractions, histology of skin, transepidermal water loss\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic KO with biochemical substrate identification, replicated independently\",\n      \"pmids\": [\"17311087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Elovl4 knockout mice lacking functional ELOVL4 show a significant reduction in free fatty acids longer than C26 in skin, establishing that ELOVL4 elongates C26 and longer fatty acids in vivo.\",\n      \"method\": \"Elovl4 Y270X mutant and knockout mice, biochemical fatty acid analysis of skin\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic loss-of-function with biochemical product identification, replicated across multiple labs\",\n      \"pmids\": [\"17304340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Heterozygous knock-in of the 5-bp deletion in Elovl4 does not cause retinal degeneration, establishing that haploinsufficiency is not the disease mechanism in STGD3; instead, dominant negative effects of mutant protein are required.\",\n      \"method\": \"Heterozygous Elovl4 knockout mice, electroretinography, retinal morphology, Western blot, fatty acid profiling\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via KO vs. knock-in comparison, replicated across multiple groups\",\n      \"pmids\": [\"16877435\", \"17254625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In Stgd3 knock-in mouse retinas, selective deficiency of C32-C36 acyl phosphatidylcholines (but no detectable cellular stress response) was found, indicating that loss of these specific lipid products rather than mutant protein toxicity underlies retinal pathology.\",\n      \"method\": \"Lipid mass spectrometry of knock-in mouse retinas, analysis of cellular stress markers\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mass spectrometry-based lipidomics in disease model, single lab\",\n      \"pmids\": [\"17983602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ELOVL4 directly catalyzes the elongation of C24:0 to C28:0 and C30:0 saturated fatty acids, and elongates C20:5n3 and C22:5n3 to a series of C28-C38 VLC-PUFAs; this was the first direct experimental evidence for ELOVL4 elongase activity.\",\n      \"method\": \"Gain-of-function adenoviral expression of mouse Elovl4 in rat neonatal cardiomyocytes and ARPE-19 cells, supplementation with labeled FA precursors, fatty acid profiling\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical gain-of-function assay with substrate identification, highly cited and foundational\",\n      \"pmids\": [\"18728184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ELOVL4 protein does not participate in the biosynthesis of docosahexaenoic acid (DHA, 22:6n3) from shorter-chain precursors (18:3n3 and 22:5n3); siRNA-mediated silencing of ELOVL4 in 661W cone cells did not reduce DHA synthesis.\",\n      \"method\": \"siRNA knockdown of ELOVL4 in 661W cells, fatty acid analysis\",\n      \"journal\": \"Advances in experimental medicine and biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, direct KD experiment with negative result, but negative finding is mechanistically informative\",\n      \"pmids\": [\"20238022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Photoreceptor-specific conditional knockout of Elovl4 in mice causes significant decrease in retinal glycerophospholipids containing VLC-PUFAs (specifically in the sn-1 position of phosphatidylcholine), abnormal lipid droplet and lipofuscin accumulation, and photoreceptor-specific defects in visual response.\",\n      \"method\": \"Photoreceptor-specific conditional Elovl4 knockout mice, HPLC-MS lipid analysis, immunofluorescence, histology, electroretinography\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — conditional KO with precise lipidomic and functional characterization, multiple orthogonal methods\",\n      \"pmids\": [\"22199362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ELOVL4 protein preferentially elongates 20:5n3 (EPA) over 20:4n6 and 22:6n3 (DHA) to produce C28-C38 VLC-PUFAs; only ELOVL4-expressing cells synthesize these VLC-PUFAs from C20-C22 PUFA precursors.\",\n      \"method\": \"Expression of ELOVL4 in pheochromocytoma cells, supplementation with individual FA substrates and combinations, GC-MS fatty acid profiling\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct enzymatic assay in cell culture, single lab but multiple substrate conditions\",\n      \"pmids\": [\"22158834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The STGD3-associated truncated ELOVL4 mutant lacks intrinsic condensation (elongase) activity in cell-based and cell-free microsome assays; co-expression of mutant with wild-type ELOVL4 shows a large dominant negative effect, reducing ELOVL4 localization to ER and enzymatic activity, resulting in reduced VLC-PUFA synthesis.\",\n      \"method\": \"Cell-based and cell-free microsome elongase assays, co-expression studies, VLC-PUFA quantification\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct enzymatic assay with cell-free reconstitution, dominant negative mechanism mechanistically established\",\n      \"pmids\": [\"23509295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Photoreceptor-specific ablation of Elovl4 in rods (conditional KO) depletes retinal VLC-PUFAs by up to 98% but causes no electrophysiological or behavioral deficits, whereas transgenic expression of mutant ELOVL4 (STGD3 allele) causes rod-cone dystrophy despite similar VLC-PUFA depletion; this suggests the mutant protein itself (not simply VLC-PUFA depletion) drives STGD3 pathology.\",\n      \"method\": \"Rod- and cone-specific conditional KO mice vs. STGD3 transgenic mice, GC-MS for VLC-PUFA, electroretinography, optomotor tracking, electron microscopy\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct genetic epistasis comparing conditional KO and transgenic models with multiple orthogonal phenotypic readouts\",\n      \"pmids\": [\"23479632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ELOVL4 enzymatic activity requires specific conserved histidine residues in its active site (active site histidine mutants lack condensation activity) and requires ER localization (displacing ELOVL4 from ER abolishes activity); N-glycosylation is not required for enzyme function.\",\n      \"method\": \"Active-site histidine mutagenesis, ER-retention mutants, N-glycosylation-deficient mutants expressed in cell culture, fatty acid elongation assays\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — active-site mutagenesis directly establishing catalytic mechanism, multiple mutant variants tested\",\n      \"pmids\": [\"24569140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In Xenopus laevis transgenic rods, wild-type ELOVL4 localizes to inner segments, while the STGD3 dilysine-deficient mutant is mislocalized to post-Golgi compartments and outer segment disks; co-expression of mutant and wild-type ELOVL4 in rods did NOT result in mislocalization of wild-type protein to outer segments or aggregate formation in vivo.\",\n      \"method\": \"Transgenic Xenopus laevis expressing HA-tagged ELOVL4 variants in rods, immunofluorescence microscopy\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo localization in photoreceptors, contrasts with cell culture studies, single lab\",\n      \"pmids\": [\"24833735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ELOVL4 is expressed in meibomian glands and sebaceous glands; Stgd3 mutant mice show meibomian gland abnormalities and increased blink rates resembling evaporative dry eye, establishing a role for ELOVL4-dependent VLC-FAs in meibomian gland function.\",\n      \"method\": \"Immunohistochemistry, hematoxylin-eosin staining, clinical ocular phenotyping of Stgd3 mice\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — loss-of-function mouse model with tissue-specific localization and anatomical phenotype, single lab\",\n      \"pmids\": [\"24677106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The STGD3 truncated ELOVL4 mutant (ELOVL4ΔC) forms homo-oligomers more strongly than wild-type ELOVL4, and also forms hetero-oligomers with other elongases (ELOVL1-7) more strongly than wild-type; ELOVL4ΔC can form elongase complexes with other components of the VLCFA elongation machinery.\",\n      \"method\": \"Co-immunoprecipitation in HEK293T cells, elongase activity assays for multiple acyl-CoA substrates\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — reciprocal co-IP with multiple binding partners, enzymatic activity assays, single lab\",\n      \"pmids\": [\"21139992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Transgenic expression of ELOVL4 driven by an epidermal-specific involucrin promoter in homozygous Stgd3 mice restores synthesis of epidermal C28-C36 acylceramides and (O-linoleoyl)-omega-hydroxy C28-C36 fatty acids, rescues skin barrier function, and prevents neonatal lethality; establishes that ELOVL4 is the sole enzyme synthesizing these lipids in skin.\",\n      \"method\": \"Skin-specific transgenic rescue of Elovl4 expression in homozygous Stgd3 mice, lipidomic analysis, transepidermal water loss, survival assessment\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic rescue experiment directly linking ELOVL4 enzymatic products to barrier function and survival\",\n      \"pmids\": [\"21429867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Double transgenic mice with homozygous STGD3 Elovl4 mutation (skin-rescued) develop seizures and die by P21; cultured hippocampal neurons from these mice show accelerated synaptic vesicle release kinetics (FM1-43 dye assay), which is rescued by supplementation with VLC-SFAs; establishing that ELOVL4-derived VLC-SFAs regulate presynaptic neurotransmitter release kinetics and epileptogenesis.\",\n      \"method\": \"Skin-specific rescue transgenic + homozygous knock-in mice, hippocampal slice electrophysiology, FM1-43 synaptic vesicle release assay, VLC-SFA supplementation rescue\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic model with direct rescue by VLC-SFA supplementation, electrophysiology, multiple orthogonal methods\",\n      \"pmids\": [\"29168048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ELOVL4-derived very long chain ceramides (VLC-ceramides, ≥C26) colocalize with tight junction complexes in retinal endothelial cells; ELOVL4 overexpression stabilizes tight junctions and prevents VEGF- and IL-1β-induced permeability; intravitreal AAV2-hELOVL4 delivery reduces diabetes-induced retinal vascular permeability.\",\n      \"method\": \"ELOVL4 overexpression and AAV delivery in cell culture and mouse model, permeability assays, ultrastructural and lipidomic analysis, Western blot for TJ proteins\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function in vitro and in vivo with mechanistic TJ protein readouts and lipidomic colocalization, multiple orthogonal methods\",\n      \"pmids\": [\"29362226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"VLC-PUFA-containing lipids are enriched in photoreceptor outer segment disks; in neurons, VLC-SFAs are enriched in synaptic vesicles where they regulate the kinetics of presynaptic neurotransmitter release essential for normal neuronal function.\",\n      \"method\": \"Lipid fractionation, mass spectrometry in retina and brain, synaptic vesicle preparations, electrophysiology in VLC-SFA-deficient mice\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — review synthesizing multiple prior experimental findings from same group, original data cited in incorporated studies\",\n      \"pmids\": [\"33556440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The W246G ELOVL4 knock-in rat (SCA34 model) shows that the W246G mutation selectively impairs VLC-SFA synthesis but not VLC-PUFA synthesis in retina and skin; homozygous rats show reduced ERG a- and b-wave amplitudes (retinal dysfunction) without photoreceptor degeneration, revealing a role for VLC-SFAs in regulating retinal function independent of neurodegeneration.\",\n      \"method\": \"Knock-in rat model, GC-MS lipid analysis, electroretinography, optical coherence tomography, histology, immunolabeling\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — knock-in rat model with precise lipid biochemistry separating VLC-SFA vs VLC-PUFA contributions, multiple orthogonal phenotypic measures\",\n      \"pmids\": [\"32780351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"W246G mutant ELOVL4 rats (SCA34 model) show impaired long-term potentiation at parallel fiber-Purkinje cell synapses and impaired long-term depression at climbing fiber-Purkinje cell synapses, with early motor deficits but no cerebellar neurodegeneration at 6 months; establishing that ELOVL4 VLC-SFAs are required for cerebellar synaptic plasticity.\",\n      \"method\": \"Knock-in rat, cerebellar slice electrophysiology (LTP/LTD recordings), rotarod motor testing, neuroanatomical analysis\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — electrophysiology with defined synaptic plasticity readouts in genetic model, multiple orthogonal methods\",\n      \"pmids\": [\"34227061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SCA34-causing ELOVL4 mutations L168F and W246G are deficient in VLC-SFA biosynthesis (especially W246G, which shows negligible VLC-SFA synthesis) but retain VLC-PUFA biosynthetic capability; L168F shows a gain-of-function producing 38:5n3 not made by WT; this differential loss of VLC-SFA vs. VLC-PUFA production may explain tissue-specific pathology (brain/skin but not retina) in SCA34.\",\n      \"method\": \"Expression of WT and mutant ELOVL4 in cell culture, supplementation with VLC-PUFA and VLC-SFA precursors, GC-MS quantification of FA methyl esters\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct enzymatic assay comparing multiple disease-causing variants, two substrate classes tested, clear mechanistic differentiation\",\n      \"pmids\": [\"36464075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Five SCA34-causing ELOVL4 mutants produce shorter ultra-long-chain (ULC) polyunsaturated FA-containing phosphatidylcholines than wild-type; structural modeling places substituted residues in transmembrane helices interacting with the ω-end region of the substrate acyl-CoA, explaining incomplete elongation; heterozygous Q180P and homozygous W246G mouse embryonic stem cells show neuronal differentiation-dependent reduction of ULC-PCs.\",\n      \"method\": \"Cell-based phosphatidylcholine elongation assay for 5 SCA34 mutants, knock-in mouse embryonic stem cells, neuronal differentiation, lipidomics, structural modeling\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct enzymatic assay for multiple mutants plus knock-in stem cell model with neuronal differentiation, structural model for mechanism\",\n      \"pmids\": [\"36748939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In W246G ELOVL4 mutant rat cerebellum, miniature EPSC frequency (but not amplitude) is reduced at Purkinje cell synapses, indicating a presynaptic defect in excitatory transmission; miniature IPSC frequency and amplitude are increased; paired-pulse ratio changes suggest opposite effects on release probability at parallel fiber vs. climbing fiber synapses; dendritic spine density is reduced in Purkinje cells.\",\n      \"method\": \"Patch-clamp electrophysiology (mEPSC, mIPSC recordings), paired-pulse ratio, high-frequency stimulation, dendritic spine morphometry in SCA34 knock-in rats\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — detailed patch-clamp recordings identifying specific presynaptic and postsynaptic mechanisms, multiple synaptic parameters measured\",\n      \"pmids\": [\"37491316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Elovl4 is a downstream target of the NOTCH-RIPK4-IRF6 tumor suppressor axis in epidermis; loss of Elovl4 in skin triggers squamous cell carcinoma development, and overexpression of Elovl4 suppresses tumor growth in Ripk4-deficient keratinocytes.\",\n      \"method\": \"Autochthonous mouse tumor models (Pik3caH1047R oncogene), in vivo CRISPR screening, Elovl4 loss-of-function and overexpression rescue experiments in keratinocytes\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo CRISPR screen combined with rescue overexpression and multiple genetic models establishes pathway position\",\n      \"pmids\": [\"36765696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In rat spermatocytes, ELOVL4 protein is a germ cell-specific product (absent from Sertoli cells), displays the highest protein levels and elongase activity in spermatocytes, and is responsible for elongation of arachidonate to C26-C32 polyunsaturated FAs present in germ cell sphingolipids.\",\n      \"method\": \"Immunohistochemistry, Western blot, [3H]arachidonate radiolabeled elongation assay in isolated germ cell populations and Sertoli cells\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct radiolabeled substrate assay in primary cell populations, cell-type-specific protein expression confirmed, single lab\",\n      \"pmids\": [\"29724783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A novel L168S ELOVL4 variant is deficient in both VLC-SFA and VLC-PUFA biosynthesis in cell culture, differentiating it from L168F (which retains VLC-PUFA synthesis) and suggesting combined VLC-SFA and VLC-PUFA deficiency underlies early-childhood SCA34 with retinal dysfunction.\",\n      \"method\": \"Expression of L168S ELOVL4 variant in cell culture, supplementation with VLC-PUFA and VLC-SFA precursors, GC-MS fatty acid profiling\",\n      \"journal\": \"Acta neuropathologica communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct enzymatic assay, single lab, single variant studied\",\n      \"pmids\": [\"37568198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SCA34 patient-derived fibroblasts show mislocalization of ELOVL4 protein appearing punctate and aggregated (not in normal ER distribution), supporting dominant negative effect of the L168F mutation on protein localization in human cells.\",\n      \"method\": \"Immunohistochemistry of patient-derived dermal fibroblasts\",\n      \"journal\": \"Neurology. Genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single localization method in patient cells, no functional readout, single lab\",\n      \"pmids\": [\"32211516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MYCN binds to the ELOVL4 promoter in proximity to HDAC1, HDAC2, and Sp1 to transcriptionally repress ELOVL4 expression; ELOVL4 positively regulates neuronal differentiation and lipid droplet accumulation in neuroblastoma cells; MYCN silencing increases FA34:6 production.\",\n      \"method\": \"ChIP for MYCN at ELOVL4 promoter, MYCN siRNA knockdown with FA34:6 metabolite measurement, neuronal differentiation assays in neuroblastoma cells\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ChIP demonstrating transcription factor binding, functional silencing with metabolite readout, single lab\",\n      \"pmids\": [\"34333551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Contact cooling of wounded skin to 20°C induces ELOVL4 expression in injured epidermis; ELOVL4-derived DHA and EPA dampen TNFα and other pro-inflammatory cytokine expression, promoting the transition from inflammation to the proliferation phase of wound healing.\",\n      \"method\": \"Skin injury model, skin organoids, bulk/single-cell RNA-seq, spatial transcriptomics, in vivo ELOVL4 perturbation, cytokine measurement, wound healing rate quantification\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo functional perturbation with mechanistic cytokine readout, multiple transcriptomic methods, single lab\",\n      \"pmids\": [\"40083712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Testis-specific knockout of Elovl4 (Stra8-Cre) abolishes VLC-PUFA (>C26) synthesis in testes, causes abnormal spermatogenesis, reduced sperm count, sperm malformation, markedly decreased sperm motility with altered Defbs gene family expression, and reduced male fertility.\",\n      \"method\": \"Testis-specific Elovl4 conditional KO mice, lipid analysis by GC-MS, sperm motility and morphology assessment, RT-PCR/qPCR/Western blot/immunohistochemistry for Defbs expression\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — conditional KO with direct biochemical (lipid) and functional (fertility) readouts, multiple orthogonal methods\",\n      \"pmids\": [\"41495266\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ELOVL4 is an ER-resident fatty acid elongase that catalyzes the rate-limiting condensation step in the biosynthesis of very long chain saturated fatty acids (VLC-SFAs, ≥C28) and very long chain polyunsaturated fatty acids (VLC-PUFAs, C28–C38), using C26 FAs and C20–C22 PUFAs as preferred substrates; its active site histidines and ER localization are both required for activity, and it functions in photoreceptors (producing VLC-PUFAs enriched in outer segment phosphatidylcholines), neurons (producing VLC-SFAs enriched in synaptic vesicles that regulate presynaptic neurotransmitter release kinetics and cerebellar synaptic plasticity), skin (producing acylceramides essential for epidermal permeability barrier), retinal endothelium (producing ceramides that stabilize tight junctions), testes (producing VLC-PUFAs required for spermatogenesis and male fertility), and meibomian glands; disease-causing truncation mutations lose the C-terminal dilysine ER-retention signal, causing mislocalization to aggresomes and dominant negative sequestration of wild-type ELOVL4, while SCA34-causing missense mutations (e.g., L168F, W246G) selectively impair VLC-SFA but not VLC-PUFA biosynthesis, explaining their distinct tissue-specific neurological rather than retinal phenotype.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ELOVL4 is an endoplasmic reticulum-resident fatty acid elongase that catalyzes the condensation step in the biosynthesis of very long chain fatty acids, generating both very long chain saturated fatty acids (VLC-SFAs, \\u2265C28) from C24:0\\u2013C26:0 precursors and very long chain polyunsaturated fatty acids (VLC-PUFAs, C28\\u2013C38) from C20\\u2013C22 PUFAs such as EPA, with preferential elongation of 20:5n3 over DHA [#12, #15]. Its catalytic activity depends on conserved active-site histidine residues and on ER localization, but not on N-glycosylation [#18]; ER retention is enforced by a C-terminal dilysine motif [#1]. These elongation products serve distinct tissue programs: in skin ELOVL4 is the sole enzyme producing omega-O-acylceramides and \\u2265C28 free fatty acids required for the epidermal permeability barrier, and its loss causes neonatal-lethal barrier failure rescued by epidermis-specific re-expression [#7, #8, #22]; in photoreceptors it supplies VLC-PUFAs enriched in outer-segment phosphatidylcholines [#14]; in neurons VLC-SFAs in synaptic vesicles set presynaptic neurotransmitter release kinetics and cerebellar synaptic plasticity [#23, #27]; in retinal endothelium VLC-ceramides stabilize tight junctions [#24]; and in testis VLC-PUFAs are required for spermatogenesis and male fertility [#37]. ELOVL4 was first identified through a 5-bp deletion causing autosomal dominant Stargardt-like macular dystrophy (STGD3) [#0]; this and other C-terminal truncations delete the dilysine signal, mislocalize the protein to aggresome-like inclusions, and sequester wild-type ELOVL4, defining a dominant-negative mechanism rather than haploinsufficiency [#1, #4, #10, #16]. By contrast, SCA34-causing missense mutations (e.g., L168F, W246G) selectively impair VLC-SFA but largely spare VLC-PUFA biosynthesis, accounting for their neurological rather than retinal presentation [#26, #28, #29].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Established ELOVL4 as a photoreceptor-expressed gene whose truncation causes a dominant macular dystrophy, linking a putative elongase to inherited retinal disease.\",\n      \"evidence\": \"Recombination mapping and sequencing of STGD3 families with homology analysis to yeast VLCFA enzymes\",\n      \"pmids\": [\"11138005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No direct enzymatic activity demonstrated\", \"Substrates and products unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined the wild-type ER localization of ELOVL4 via a C-terminal dilysine motif and showed disease truncations mislocalize, framing a localization-based pathology.\",\n      \"evidence\": \"Immunofluorescence/immuno-EM in human photoreceptors and transfected COS-7/CHO/NIH-3T3/HEK293 cells, organelle markers, TUNEL\",\n      \"pmids\": [\"15028284\", \"15073583\", \"15557430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mislocalization alone or loss of catalytic product drives disease unresolved\", \"No enzymatic activity tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated a dominant-negative mechanism: truncated ELOVL4 forms aggresomes, binds wild-type protein, recruits it out of the ER, and triggers the UPR.\",\n      \"evidence\": \"Co-IP, FRET, 2D gel, sucrose gradient, BiP/CHOP Western blot in COS-7/HEK293 cells\",\n      \"pmids\": [\"16036915\", \"16163264\", \"16145543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-culture overexpression may not reflect photoreceptor context\", \"Did not yet quantify loss of catalytic output\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genetic loss-of-function in mice established ELOVL4 as essential for skin VLC-FA/acylceramide synthesis and proved haploinsufficiency is not the STGD3 mechanism.\",\n      \"evidence\": \"Knock-in 5-bp deletion and knockout mice, epidermal lipidomics, EM of lamellar bodies, transepidermal water loss, ERG of heterozygotes\",\n      \"pmids\": [\"17208947\", \"17311087\", \"17304340\", \"16877435\", \"17254625\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Neonatal lethality precluded study of retinal and neuronal roles\", \"Precise C26 substrate-to-product step not directly assayed in vitro\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Provided the first direct biochemical evidence that ELOVL4 is the elongase, defining both VLC-SFA and VLC-PUFA product spectra.\",\n      \"evidence\": \"Adenoviral gain-of-function expression with labeled FA precursors and FA profiling in cardiomyocytes and ARPE-19 cells\",\n      \"pmids\": [\"18728184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which condensation residues are catalytic\", \"Substrate preference among PUFAs not yet ranked\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Refined substrate selectivity and defined the photoreceptor lipid product, while excluding ELOVL4 from DHA synthesis.\",\n      \"evidence\": \"Photoreceptor conditional KO with HPLC-MS lipidomics; ELOVL4 expression with individual substrate supplementation and GC-MS; siRNA in 661W cells\",\n      \"pmids\": [\"22199362\", \"22158834\", \"20238022\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of VLC-PUFA loss in vision not yet dissected from mutant toxicity\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Genetic epistasis separated VLC-PUFA depletion from mutant-protein toxicity, and enzymology confirmed the truncated mutant is catalytically dead and dominant-negative.\",\n      \"evidence\": \"Rod/cone conditional KO vs STGD3 transgenic mice with ERG/optomotor; cell-free microsome elongase assays with co-expression\",\n      \"pmids\": [\"23479632\", \"23509295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why VLC-PUFA depletion alone is tolerated in mouse rods left open\", \"Identity of the toxic species in transgenic retina unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established the catalytic and localization requirements of ELOVL4 and extended its roles to meibomian gland function.\",\n      \"evidence\": \"Active-site histidine, ER-retention, and glycosylation mutants with elongation assays; immunohistochemistry and ocular phenotyping of Stgd3 mice; in vivo Xenopus rod localization\",\n      \"pmids\": [\"24569140\", \"24677106\", \"24833735\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo Xenopus data did not reproduce wild-type sequestration seen in cell culture\", \"Structural basis of substrate selection unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified VLC-SFAs as regulators of presynaptic vesicle release, explaining neurological phenotype through synaptic dysfunction.\",\n      \"evidence\": \"Skin-rescued homozygous STGD3 mice, hippocampal FM1-43 release assay, electrophysiology, VLC-SFA supplementation rescue\",\n      \"pmids\": [\"29168048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target through which VLC-SFAs alter release kinetics unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended ELOVL4 products to retinal endothelial tight-junction stabilization and germ-cell sphingolipid synthesis.\",\n      \"evidence\": \"ELOVL4 overexpression/AAV in retinal endothelium with permeability and TJ readouts; radiolabeled arachidonate elongation in isolated testicular germ cells\",\n      \"pmids\": [\"29362226\", \"29724783\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which VLC-ceramides stabilize tight junctions not defined\", \"Germ-cell findings single-lab, primary-cell based\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined the SCA34 mechanism: missense mutations selectively impair VLC-SFA synthesis, accounting for tissue-specific neurological pathology.\",\n      \"evidence\": \"W246G knock-in rat with GC-MS lipid analysis, ERG, OCT, histology; patient fibroblast localization\",\n      \"pmids\": [\"32780351\", \"32211516\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Patient-fibroblast localization is single-method, low-confidence\", \"Link between VLC-SFA loss and retinal function decrement not mechanistic\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated that ELOVL4 VLC-SFAs are required for cerebellar synaptic plasticity and that ELOVL4 is transcriptionally repressed by MYCN in neuroblastoma.\",\n      \"evidence\": \"Cerebellar slice LTP/LTD recordings and rotarod in W246G rats; MYCN ChIP at ELOVL4 promoter with siRNA and metabolite/differentiation assays\",\n      \"pmids\": [\"34227061\", \"34333551\", \"33556440\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How VLC-SFAs influence Purkinje synapse plasticity at molecular level unknown\", \"Functional consequence of MYCN-driven repression in tumors not fully resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Resolved structural and biochemical basis of SCA34 variant heterogeneity and placed ELOVL4 in an epidermal tumor-suppressor axis and wound-healing program.\",\n      \"evidence\": \"Cell-based PC elongation assays for multiple variants plus structural modeling and knock-in ES cells; detailed patch-clamp in W246G rats; NOTCH-RIPK4-IRF6/CRISPR tumor models; cooling-induced wound-healing model\",\n      \"pmids\": [\"36464075\", \"36748939\", \"36465696\", \"37491316\", \"37568198\", \"36765696\", \"40083712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct enzyme structure not solved (modeling only)\", \"Mechanism by which ELOVL4 loss permits squamous carcinoma not fully defined\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Established a required role for ELOVL4 VLC-PUFAs in spermatogenesis and male fertility.\",\n      \"evidence\": \"Testis-specific conditional KO mice with GC-MS lipidomics, sperm phenotyping, and Defbs expression analysis\",\n      \"pmids\": [\"41495266\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How VLC-PUFA loss alters Defbs expression and sperm motility mechanistically unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular targets through which ELOVL4-derived VLC lipids act on synaptic release machinery, tight junctions, and sperm function remain undefined, and no experimental structure of the enzyme exists.\",\n      \"evidence\": \"Not yet addressed in the available corpus\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimentally determined ELOVL4 structure\", \"Lipid-effector interactions at synapses and junctions unmapped\", \"Regulation of ELOVL4 expression across tissues incompletely defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [12, 15, 18, 28]},\n      {\"term_id\": \"GO:0016747\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 2, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [12, 15, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ELOVL4\", \"ELOVL1\", \"ELOVL2\", \"ELOVL3\", \"ELOVL5\", \"ELOVL6\", \"ELOVL7\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":5,"faith_total":5,"faith_pct":100.0}}